| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/28/2006 | WO2006100089A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 09/28/2006 | WO2006099875A1 Antibodies against cd38 for treatment of multiple myeloma |
| 09/28/2006 | WO2006099871A1 Polypeptides and nucleic acids encoding same |
| 09/28/2006 | WO2006099747A1 Method for isolation of soluble polypeptides |
| 09/28/2006 | WO2006099701A1 Inhibitor of endogenous human interferon - gamma |
| 09/28/2006 | WO2006086396A3 Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 09/28/2006 | WO2006084646A3 Sms 22 gene and gene product that plays a role in the synthesis of vitamin c |
| 09/28/2006 | WO2006077101A3 Ager-peptides and use thereof |
| 09/28/2006 | WO2006069403A3 Methods for producing soluble multi-membrane-spanning proteins |
| 09/28/2006 | WO2006069331A3 Compositions and methods for producing recombinant proteins |
| 09/28/2006 | WO2006067221A3 Michael-type addition reaction functionalised peg hydrogels with factor xiiia incorporated biofactors |
| 09/28/2006 | WO2006059113A3 Fusion proteins comprising a non-cytotoxic protease, a targeting moiety, a protease cleavage site and a translocation domain |
| 09/28/2006 | WO2006055004A8 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 09/28/2006 | WO2006051545A3 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/28/2006 | WO2006048777A3 Modified growth hormones |
| 09/28/2006 | WO2006048655A3 Methods of modulating the immune system using anti-inflammatory polypeptides which interact with toll receptor function |
| 09/28/2006 | WO2006031330A3 METHOD OF REDUCING THE EFFECTS OF Aβ AND COMPOSITIONS THEREFORE |
| 09/28/2006 | WO2006015258A3 Methods and compositions related to argonaute proteins |
| 09/28/2006 | WO2005074650A3 Modified human four helical bundle polypeptides and their uses |
| 09/28/2006 | WO2005072292A3 Methods for enhancing radiation therapy |
| 09/28/2006 | WO2005054280A3 Methods of producing disease-resistant animals |
| 09/28/2006 | WO2005047315A3 Optimized expression of hpv 58 l1 in yeast |
| 09/28/2006 | WO2005034732A3 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 09/28/2006 | WO2004080404A3 Il-2 transmembrane constructs |
| 09/28/2006 | WO2004067716A3 Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer |
| 09/28/2006 | WO2003103572A3 Modified glucagon-like peptide-1 analogs |
| 09/28/2006 | WO2003076578A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/28/2006 | WO2002008267A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/28/2006 | US20060218677 Novel gene osisap1 of rice confers tolerance to stresses and a method thereof |
| 09/28/2006 | US20060218676 Compositions and method for modulation of plant cell division |
| 09/28/2006 | US20060218669 Sialylation of glycoproteins in plants |
| 09/28/2006 | US20060218667 Plant-produced recombinant aprotinin and aprotinin variants |
| 09/28/2006 | US20060218666 Nucleotide sequences encoding anthonomous toxic polypeptides from bacillus thuringiensis |
| 09/28/2006 | US20060218665 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 09/28/2006 | US20060218659 L450 polypeptide and nucleic acid encoding it; transgenic plant |
| 09/28/2006 | US20060218658 transforming a population of plant cells which comprises at least one marker protein having a direct or indirect toxic effect; genetic engineering using DNA construct capable of reducing the expression, amount, activity and/or function of the marker protein |
| 09/28/2006 | US20060218656 Transgenic mice containing mGluR7 metabotropic glutamate receptor gene disruptions |
| 09/28/2006 | US20060218655 Used for identifying a drug capable of treating a B cell lymphoma, capable of depleting or killing cells expressing human CD20, or capable of inducing an Fc-mediated effector cell response; testing the safety or efficacy of anti-human CD20 therapy |
| 09/28/2006 | US20060218653 determining that a single nucleotide point mutation in the fourth exon of the nucleic acid sequence encoding dog CLN5 results in the production of a variant soluble lysosomal glycoprotein, specifically CLN5, which exhibits aberrant functional activity |
| 09/28/2006 | US20060217891 Method of designing physiologically active peptide and use thereof |
| 09/28/2006 | US20060217535 Hemipteran muscarinic receptor |
| 09/28/2006 | US20060217531 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 09/28/2006 | US20060217530 Active against C5a receptors on polymorphonuclear leukocytes and macrophages; peptidomimetics; for treatment of inflammation |
| 09/28/2006 | US20060217529 Method for Producing Insulin From a Natural Source and Insulin Produced by Said Method |
| 09/28/2006 | US20060217342 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 09/28/2006 | US20060217338 Influenza nucleic acids, polypeptides, and uses thereof |
| 09/28/2006 | US20060217319 Method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 09/28/2006 | US20060217317 Proteases of human kallikrein 2 (hK2); tissue imaging |
| 09/28/2006 | US20060217314 Feline hepatocyte growth factor |
| 09/28/2006 | US20060217312 Charged lipoprotein complexes and their uses |
| 09/28/2006 | US20060217310 Fibroblast growth factor 1 (FGF-1) used for skin care |
| 09/28/2006 | US20060217304 Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders |
| 09/28/2006 | US20060217302 Paralytic peptide for use in neuromuscular therapy |
| 09/28/2006 | US20060217300 Analogues of glp-1 |
| 09/28/2006 | US20060217299 Degradation inhibitor for hepatitis b virus x interacting protein |
| 09/28/2006 | US20060217298 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 09/28/2006 | US20060217296 For treatment and/or prevention of loss of body weight and body fat, cachexia, stimulation of appetite, food intake, stimulation of weight gain, and/or increasing body fat mass |
| 09/28/2006 | US20060217294 Compounds binding to p-selectin |
| 09/28/2006 | US20060217290 Insulin analogs having protracted time action |
| 09/28/2006 | US20060216807 Membrane for removing proteases from liquids |
| 09/28/2006 | US20060216789 Method for the production of bacterial toxins |
| 09/28/2006 | US20060216788 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS |
| 09/28/2006 | US20060216787 Modified Shine-Dalgarno sequences and methods of uses thereof |
| 09/28/2006 | US20060216786 Feline interferon-alpha proteins |
| 09/28/2006 | US20060216785 Genetic engineering; fusion protein; comprising a recombinant vector containing a nucleic acid sequence encoding a ubiquitin like molecule (UBL) molecule selected from the group of SUMO, RUB, HUB, URM1, and ISG15 operably linked to a promoter suitable for expression in the desired host cell |
| 09/28/2006 | US20060216784 Process for production of polypeptides |
| 09/28/2006 | US20060216783 Polypeptide factor from a thermophilic eubacterial species and use thereof in the production of functional, heterologous proteins in an expression host |
| 09/28/2006 | US20060216782 Methods for expression and purification of immunotoxins |
| 09/28/2006 | US20060216767 Docetaxel immunoassay |
| 09/28/2006 | US20060216758 Antibodies to transferrin receptor-like proteins |
| 09/28/2006 | US20060216750 New lipid binding protein 1 |
| 09/28/2006 | US20060216749 Chimeric gaba receptor |
| 09/28/2006 | US20060216748 Genes differentially expressed in breast cancer |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216732 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound |
| 09/28/2006 | US20060216727 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/28/2006 | US20060216719 Novel short isoform of Annexin A10 at chromosome 4q, termed Annexin 10s (ANXA10s) and methods of use |
| 09/28/2006 | US20060216717 Novel human polynucleotides and the polypeptides encoded thereby |
| 09/28/2006 | US20060216711 Variants of cytochrome c and methods of diagnosis of thrombocytopenia |
| 09/28/2006 | US20060216710 Screening for compound that activates or inhibits activity of Aster Associated Protein; over-expression disrupts mitotic spindle assembly and leads to aberrant and abortive mitosis |
| 09/28/2006 | US20060216709 Midkine-like protein |
| 09/28/2006 | US20060216706 Proteins associated with cell growth, differentiation, and death |
| 09/28/2006 | US20060216705 Transcription activation complex and utilization thereof |
| 09/28/2006 | US20060216699 Peptides for the detection of HIV-1 group O |
| 09/28/2006 | US20060216698 Fusion expression vector containing the His-tagged Vitreoscilla hemoglobin coding gene |
| 09/28/2006 | US20060216691 contacting MHC/HLA molecule with a pool of HCV-peptides whereby a HCV-peptide which has a binding capacity to MHC/HLA molecule binds to such MHC/HLA molecule and form a complex, detecting the complexe, assaying the complex in a T cell assay for T cell activation capacity, assaying T cell epitopes |
| 09/28/2006 | US20060216356 Detection of antibacterial activity in excretory secretory product of adult trichuris suis |
| 09/28/2006 | US20060216330 Peptides having an ace inhibiting effect |
| 09/28/2006 | US20060216314 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen phl p7 |
| 09/28/2006 | US20060216309 Identification of genes |
| 09/28/2006 | US20060216308 Genomic sequence that encode ptorprotein; drug for prevention, therapy of infections; induce immunology response |
| 09/28/2006 | US20060216307 Vaccine composition |
| 09/28/2006 | US20060216306 Epitopes of human immunodeficiency virus-1 |
| 09/28/2006 | US20060216305 Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use |
| 09/28/2006 | US20060216304 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 09/28/2006 | US20060216303 Processes and products with modified antibodies of human milk fat globule specificity |
| 09/28/2006 | US20060216302 Immunological markers |
| 09/28/2006 | US20060216301 Kdr peptides and vaccines containing the same |
| 09/28/2006 | US20060216299 Cell cycle targets and peptides |